Key stats
About BLINKLAB LIMITED
Sector
Industry
Headquarters
Sydney
Website
Founded
2021
ISIN
AU0000322851
FIGI
BBG01LNYJZF8
Blinklab Ltd engages in research and development of mental health care through mobile solutions. It offers smartphone-based application with an e-platform that serves as a medical device to perform neurometric tests to aid in the diagnosis of autism spectrum disorder, attention deficit hyperactivity disorder, schizophrenia, and other neurodevelopmental conditions. The company was founded by Henk-Jan Boele, Samuel Wang, Anton Uvarov, Cornelis Pieter Boele, Sebastiaan K.E. Koekkoek, and Chris de Zeeuw on August 17, 2021 and is headquartered in Sydney, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BB1 is 0.270 AUD — it has decreased by 10.00% in the past 24 hours. Watch BLINKLAB LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange BLINKLAB LIMITED stocks are traded under the ticker BB1.
BB1 stock has fallen by 15.62% compared to the previous week, the month change is a 29.87% fall, over the last year BLINKLAB LIMITED has showed a 10.00% decrease.
BB1 stock is 13.21% volatile and has beta coefficient of −2.02. Track BLINKLAB LIMITED stock price on the chart and check out the list of the most volatile stocks — is BLINKLAB LIMITED there?
No, BB1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BB1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BLINKLAB LIMITED stock right from TradingView charts — choose your broker and connect to your account.